Results for tag: "Repaglinide"

Repaglinide is a drug used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as meglitinides, which work by stimulating the pancreas to produce more insulin. Repaglinide is taken orally before meals to help control blood sugar levels. It is often used in combination with other diabetes medications, such as metformin or sulfonylureas. Repaglinide is a relatively new drug, having been approved by the US Food and Drug Administration in 1997. It is generally well-tolerated, with few side effects. Common side effects include headache, dizziness, and nausea. It is important to note that repaglinide should not be used in patients with type 1 diabetes or in those with severe kidney or liver disease. In the Repaglinide market, some of the major players include Novo Nordisk, Sanofi, and Eli Lilly. Other companies involved in the market include Merck, Boehringer Ingelheim, and AstraZeneca. Show Less Read more